Abstract

For many years the spectrum of gluten-related disorders had been limited only to celiac disease and its typical gastrointestinal symptoms. In the last few years, not only new disorders like non-celiac gluten sensitivity have been described, but also pathogeneses of celiac disease and wheat allergy have been better understood. It is also known that impaired gluten tolerance in many cases leads to appearance of extraintestinal symptoms that may affect any organ or system of the human body including the nervous system that may be the cause of some neurological disorders such as ataxia, neuropathy, autism spectrum disorder (ASD) or schizophrenia. In this paper we present the spectrum of neurological disorders, whose pathogeneses may depend on gluten ingestion and some proposed mechanisms elucidating those pathogeneses.

References

• 1. Addolorato G., Di Giuda D., De Rossi G., Valenza V., Domenicali M., Caputo F., Gasbarrini A., Capristo E., Gasbarrini G.: Regional cerebral hypoperfusion in patients with celiac disease. Am. J. Med., 2004; 116: 312-317
  Google Scholar
• 2. Alaedini A., Okamoto H., Briani C., Wollenberg K., Shill H.A., Bushara K.O., Sander H.W., Green P.H., Hallett M., Latov N.: Immune cross-reactivity in celiac disease: Anti-gliadin antibodies bind to neuronal synapsin I. J. Immunol., 2007; 178: 6590-6595
  Google Scholar
• 3. Alehan F., Ozçay F., Erol I., Canan O., Cemil T.: Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia, 2008; 28: 945-949
  Google Scholar
• 4. Andrade C., Rocha H., Albuquerque A., Sá M.J.: Gluten chorea. Clin. Neurol. Neurosurg., 2015; 138: 8-9
  Google Scholar
• 5. Arentz–Hansen H., McAdam S.N., Molberg Ø., Fleckenstein B., Lundin K.E., Jorgensen T.J., Jung G., Roepstroff P., Sollid L.M.: Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology, 2002; 123: 803-809
  Google Scholar
• 6. Azhary H., Farooq M.U., Bhanushali M., Majid A., Kassab M.Y.: Peripheral neuropathy: Differential diagnosis and management. Am. Fam. Physician., 2010; 81: 887-892
  Google Scholar
• 7. Batista I.C., Gandolfi L., Nobrega Y.K., Almeida R.C., Almeida L.M., Campos Junior D., Pratesi R.: Autism spectrum disorder and celiac disease: no evidence for a link. Arq. Neuropsiquiatr., 2012; 70: 28-33
  Google Scholar
• 8. Biesiekierski J.R.: What is gluten? J. Gastroenterol. Hepatol., 2017; 32: 78-81
  Google Scholar
• 9. Bittner C., Grassau B., Frenzel K., Baur X.: Identification of wheat gliadins as an allergen family related to baker’s asthma. J. Allergy Clin. Immunol., 2008; 121: 744-749
  Google Scholar
• 10. Bonder M.J., Tigchelaar E.F., Cai X., Trynka G., Cenit M.C., Hrdlickova B., Zhong H., Vatanen T., Gevers D., Wijmenga C., Wang Y., Zhernakova A.: The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med., 2016; 8: 45
  Google Scholar
• 11. Brottveit M., Beitnes A.C., Tollefsen S., Bratlie J.E., Jahnsen F.L., Johansen F.E., Sollid L.M., Lundin K.E.: Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am. J. Gastroenterol., 2013; 108: 842-850
  Google Scholar
• 12. Brusse E., Maat-Kievit J.A., van Swieten J.C.: Diagnosis and management of early- and late-onset cerebellar ataxia. Clin. Genet., 2007; 71: 12-24
  Google Scholar
• 13. Bushara K.O.: Neurologic presentation of celiac disease. Gastroenterology, 2005; 128: S92-S97
  Google Scholar
• 14. Cade R., Privette M., Fregly M., Rowland N., Sun Z., Zele V., Wagemaker H., Edelstein C.: Autism and schizophrenia: Intestinal disorders. Nutr. Neurosci., 2000; 3: 57-72
  Google Scholar
• 15. Caminero A., Nistal E., Herrán A.R., Pérez-Andrés J., Vaquero L., Vivas S., de Morales J.M., Casqueiro J.: Gluten metabolism in humans: Involvement of the gut microbiota. W: Wheat and Rice in Disease Prevention and Health – Benefits, risks and mechanisms of whole grains in health promotion, red.: R.R. Watson, V.R. Preedy, S. Zibadi, Academic Press, 2014, 157-170
  Google Scholar
• 16. Cascella N.G., Kryszak D., Bhatti B., Gregory P., Kelly D.L., Mc Evoy J.P., Fasano A., Eaton W.W.: Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr. Bull., 2011; 37: 94-100
  Google Scholar
• 17. Cascella N.G., Santora D., Gregory P., Kelly D.L., Fasano A., Eaton W.W.: Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients. Schizophr. Bull., 2013; 39: 867-871
  Google Scholar
• 18. Catassi C.: Gluten sensitivity. Ann. Nutr. Metab., 2015; 67: 16-26
  Google Scholar
• 19. Catassi C., Bai J.C., Bonaz B., Bouma G., Calabrò A., Carroccio A., Castillejo G., Ciacci C., Cristofori F., Dolinsek J., Francavilla R., Elli L., Green P., Holtmeier W., Koehler P. i wsp.: Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients, 2013; 5: 3839-3853
  Google Scholar
• 20. Catassi C., Fasano A.: Celiac disease diagnosis: simple rules are better than complicated algorithms. Am. J. Med., 2010; 123: 691-693
  Google Scholar
• 21. CDC, Christensen D.L., Baio J., Van Naarden Braun K., Bilder D., Charles J., Constantino J.N., Daniels J., Durkin M.S., Fitzgerald R.T., Kurzius-Spencer M., Lee L.C., Pettygrove S., Robinson C., Schulz E., Wells C., Wingate M.S., Zahorodny W., Yeargin-Allsopp M.: Prevalence and characteristics of autism spectrum disorder among children aged 8 years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveill. Summ., 2016; 65: 1-23
  Google Scholar
• 22. Chaidez V., Hansen R.L., Hertz-Picciotto I.: Gastrointestinal problems in children with autism, developmental delays or typical development. J. Autism Dev. Disord., 2014; 44: 1117-1127
  Google Scholar
• 23. Chin R.L., Latov N.: Peripheral neuropathy and celiac disease. Curr. Treat. Options Neurol., 2005; 7: 43-48
  Google Scholar
• 24. Chin R.L., Sander H.W., Brannagan T.H., Green P.H., Hays A.P., Alaedini A., Latov N.: Celiac neuropathy. Neurology, 2003; 60: 1581-1585
  Google Scholar
• 25. Chwalba A., Otto-Buczkowska E.: Role of gluten-free diet in pathogenesis of type 1 diabetes – what new? Pediatr. Endocrinol. Diabetes Metab., 2015; 21: 188-191
  Google Scholar
• 26. Cianferoni A.: Wheat allergy: diagnosis and management. J. Asthma Allergy., 2016; 9: 13-25
  Google Scholar
• 27. Clemente M.G., De Virgiliis S., Kang J.S., Macatagney R., Musu M.P., Di Pierro M.R., Drago S., Congia M., Fasano A.: Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut, 2003; 52: 218-223
  Google Scholar
• 28. Comino I., Real A., de Lorenzo L., Cornell H., López-Casado M.Á., Barro F., Lorite P., Torres M.I., Cebolla A., Sousa C.: Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut, 2011; 60: 915-922
  Google Scholar
• 29. Corbett B.A., Kantor A.B., Schulman H., Walker W.L., Lit L., Ashwood P., Rocke D.M., Sharp F.R.: A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol. Psychiatry, 2007; 12: 292-306
  Google Scholar
• 30. Coury D.L., Ashwood P., Fasano A., Fuchs G., Geraghty M., Kaul A., Mawe G., Patterson P., Jones N.E.: Gastrointestinal conditions in children with autism spectrum disorder: Developing a research agenda. Pediatrics, 2012; 130: S160-S168
  Google Scholar
• 31. Cruchet S., Lucero Y., Cornejo V.: Truths, myths and needs of special diets: Attention-deficit/hyperactivity disorder, autism, non-celiac gluten sensitivity, and vegetarianism. Ann. Nutr. Metab., 2016; 68: 43-50
  Google Scholar
• 32. Daitch L., Epperson J.N.: Celiac disease: A storm of gluten intolerance. Clin. Rev., 2011; 21: 49-55
  Google Scholar
• 33. Deli G., Bosnyak E., Pusch G., Komoly S., Feher G.: Diabetic neuropathies: diagnosis and management. Neuroendocrinology, 2013; 98: 267-280
  Google Scholar
• 34. de Magistris L., Familiari V., Pascotto A., Sapone A., Frolli A., Iardino P., Carteni M., De Rosa M., Francavilla R., Riegler G., Militerni R., Bravaccio C.: Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr., 2010; 51: 418-424
  Google Scholar
• 35. de Magistris L., Picardi A., Siniscalco D., Riccio M.P., Sapone A., Cariello R., Abbadessa S., Medici N., Lammers K.M., Schiraldi C., Iardino P., Marotta R., Tolone C., Fasano A., Pascotto A., Bravaccio C.: Antibodies against food antigens in patients with autistic spectrum disorders. Biomed. Res. Int., 2013; 2013: 729349
  Google Scholar
• 36. De Magistris L., Siniscalco D., Bravaccio C., Loguercio C.: Gut-brain axis: A new revolution to understand the pathogenesis of autism and other severe neurological diseases. W: Human Nutrition from the Gastroenterologist’s Perspective, red.: E. Grossi, P. Fabio, Springer, 2016, 49-65
  Google Scholar
• 37. Dimitrova A.K., Ungaro R.C., Lebwohl B., Lewis S.K., Tennyson C.A., Green M.W., Babyatsky M.W, Green P.H.: Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache, 2013; 53: 344-355
  Google Scholar
• 38. El Asmar R., Panigrahi P., Bamford P., Berti I., Not T., Coppa G.V., Catassi C., Fasano A.: Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology, 2002; 123: 1607-1615
  Google Scholar
• 39. Erbguth F., Himmerich H.: Nutrition and dietary supplements in neurological diseases. Nervenarzt., 2014; 85: 1501-1511
  Google Scholar
• 40. Fasano A.: Intestinal zonulin: open sesame! Gut, 2001; 49: 159-162
  Google Scholar
• 41. Fasano A.: Celiac disease – how to handle a clinical chameleon. N. Engl. J. Med., 2003; 348: 2568-2570
  Google Scholar
• 42. Fasano A.: Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am. J. Pathol., 2008; 173: 1243-1252
  Google Scholar
• 43. Fasano A.: Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer. Physiol. Rev., 2011; 91: 151-175
  Google Scholar
• 44. Fasano A., Not T., Wang W., Uzzau S., Berti I., Tommasini A., Goldblum S.E.: Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet, 2000; 355: 1518-1519
  Google Scholar
• 45. Fasano A., Uzzau S., Fiore C., Margaretten K.: The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroenterology, 1997; 112: 839-846
  Google Scholar
• 46. Fiorentino M., Sapone A., Senger S., Camhi S.S., Kadzielski S.M., Buie T.M., Kelly D.L., Cascella N., Fasano A.: Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol. Autism, 2016; 7: 49
  Google Scholar
• 47. Ford R.P.: The gluten syndrome: A neurological disease. Med. Hypotheses, 2009; 73: 438-440
  Google Scholar
• 48. Gabrielli M., Cremonini F., Fiore G., Addolorato G., Padalino C., Candelli M., De Leo M.E., Santarelli L., Giacovazzo M., Gasbarrini A., Pola P., Gasbarrini A.: Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am. J. Gastroenterol., 2003; 98: 625-629
  Google Scholar
• 49. Gaughran F., Welch J.: Schizophrenia and immune responses. W: Handbook of Neurochemistry and Molecular Neurobiology. Neuroimmunology, red.: A. Lajtha, A. Galoyan, H.O. Besedovsky, Springer, 2008, 467-488
  Google Scholar
• 50. GBD 2015 Neurological Disorders Collaborator Group: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol., 2017; 16: 877-897
  Google Scholar
• 51. Gianfrani C., Auricchio S., Troncone R.: Adaptive and innate immune responses in celiac disease. Immunol. Lett., 2005; 99: 141-145
  Google Scholar
• 52. Gobbi G., Bouquet F., Greco L., Lambertini A., Tassinari C.A., Ventura A., Zaniboni M.G.: Coeliac disease, epilepsy and cerebral calcifications. Lancet, 1992; 340: 439-443
  Google Scholar
• 53. Goldstein M.L., Morewitz S.: Autism. W: Chronic Disorders in Children and Adolescents, red.: M.L. Goldstein, S.J. Morewitz, Springer, 2011, 59-80
  Google Scholar
• 54. Green P.H., Alaedini A., Sander H.W., Brannagan T.H.3rd, Latov N., Chin R.L.: Mechanisms underlying celiac disease and its neurologic manifestations. Cell. Mol. Life Sci., 2005; 62: 791-799
  Google Scholar
• 55. Hadjivassiliou M., Aeschlimann P., Strigun A., Sanders D.S., Woodroofe N., Aeschlimann D.: Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann. Neurol., 2008; 64: 332-343
  Google Scholar
• 56. Hadjivassiliou M., Boscolo S., Davies-Jones G.A., Grünewald R.A., Not T., Sanders D.S., Simpson J.E., Tongiorgi E., Williamson C.A., Woodroofe N.M.: The humoral response in the pathogenesis of gluten ataxia. Neurology, 2002; 58: 1221-1226
  Google Scholar
• 57. Hadjivassiliou M., Davies-Jones G.A., Sanders D.S., Grünewald R.A.: Dietary treatment of gluten ataxia. J. Neurol. Neurosurg. Psychiatry, 2003; 74: 1221-1224
  Google Scholar
• 58. Hadjivassiliou M., Duker A.P., Sanders D.S.: Gluten-related neurologic dysfunction. W: Handbook of Clinical Neurology, Vol. 120 (3rd series) Neurologic Aspects of Systemic Disease Part II, red.: J. Biller, J.M. Ferro, Elsevier, 2014, 607-619
  Google Scholar
• 59. Hadjivassiliou M., Grünewald R.A., Chattopadhyay A.K., Davies-Jones G.A., Gibson A., Jarratt J.A., Kandler R.H., Lobo A., Powell T., Smith C.M.: Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet, 1998; 352: 1582-1585
  Google Scholar
• 60. Hadjivassiliou M., Grünewald R.A., Kandler R.H., Chattopadhyay A.K., Jarratt J.A., Sanders D.S., Sharrack B., Wharton S.B., Davies-Jones G.A.: Neuropathy associated with gluten sensitivity. J. Neurol. Neurosurg. Psychiatry, 2006; 77: 1262-1266
  Google Scholar
• 61. Hadjivassiliou M., Grünewald R.A., Lawden M., Davies-Jones G.A., Powell T., Smith C.M.: Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology, 2001; 56: 385-388
  Google Scholar
• 62. Hadjivassiliou M., Grünewald R.A., Sharrack B., Lobo A., Williamson C., Woodroofe N., Wood N., Davies-Jones A.: Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain, 2003; 126: 685-691
  Google Scholar
• 63. Hadjivassiliou M., Kandler R.H., Chattopadhyay A.K., Davies-Jones A.G., Jarratt J.A., Sanders D.S., Sharrack B., Grünewald R.A.: Dietary treatment of gluten neuropathy. Muscle Nerve, 2006; 34: 762-766
  Google Scholar
• 64. Hadjivassiliou M., Sanders D.S., Grünewald R.A., Woodroofe N., Boscolo S., Aeschlimann D.: Gluten sensitivity: from gut to brain. Lancet. Neurol., 2010; 9: 318-330
  Google Scholar
• 65. Hadjivassiliou M., Sanders D.S., Woodroofe N., Williamson C., Grunewald R.A.: Gluten ataxia. Cerebellum, 2008; 7: 494-498
  Google Scholar
• 66. Hausch F., Shan L., Santiago N.A., Gray G.M., Khosla C.: Intestinal digestive resistance of immunodominant gliadin peptides. Am. J. Physiol. Gastrointest. Liver Physiol., 2002; 283: G996-G1003
  Google Scholar
• 67. Hernandez L., Green P.H.: Extraintestinal manifestations of celiac disease. Curr. Gastroenterol. Rep., 2006; 8: 383-389
  Google Scholar
• 68. Jacob S., Zarei M., Kenton A., Allroggen H.: Gluten sensitivity and neuromyelitis optica: two case reports. J. Neurol. Neurosurg. Psychiatry, 2005; 76: 1028-1030
  Google Scholar
• 69. Jackson J.R., Eaton W.W., Cascella N.G., Fasano A., Kelly D.L.: Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr. Q., 2012; 83: 91-102
  Google Scholar
• 70. Kalaydjian A.E., Eaton W., Cascella N., Fasano A.: The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr. Scand., 2006; 113: 82-90
  Google Scholar
• 71. Karyekar C.S., Fasano A., Raje S., Lu R., Dowling T.C., Eddington N.D.: Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. J. Pharm. Sci., 2003; 92: 414-423
  Google Scholar
• 72. König J., Wells J., Cani P.D., García-Ródenas C.L., MacDonald T., Mercenier A., Whyte J., Troost F., Brummer R.J.: Human intestinal barrier function in health and disease. Clin. Transl. Gastroenterol., 2016; 7: e196
  Google Scholar
• 73. Kupper C.: Dietary guidelines and implementation for celiac disease. Gastroenterology, 2005; 128: S121-S127
  Google Scholar
• 74. Lammers K.M., Khandelwal S., Chaudhry F., Kryszak D., Puppa E.L., Casolaro V., Fasano A.: Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology, 2011; 132: 432-440
  Google Scholar
• 75. Lammers K.M., Lu R., Brownley J., Lu B., Gerard C., Thomas K., Rallabhandi P., Shea-Donohue T., Tamiz A., Alkan S., Netzel-Arnett S., Antalis T., Vogel S.N., Fasano A.: Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology, 2008; 135: 194-204
  Google Scholar
• 76. Lau N.M., Green P.H., Taylor A.K., Hellberg D., Ajamian M., Tan C.Z., Kosofsky B.E., Higgins J.J., Rajadhyaksha A.M., Alaedini A.: Markers of celiac disease and gluten sensitivity in children with autism. PLoS One, 2013; 8: e66155
  Google Scholar
• 77. Laukoetter M.G., Bruewer M., Nusrat A.: Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr. Opin. Gastroenterol., 2006; 22: 85-89
  Google Scholar
• 78. Lewis S.L.: Encephalopathy. W: Emergency Neurology, red.: K.L. Roos, Springer, 2012, 283-294
  Google Scholar
• 79. Lionetti E., Leonardi S., Franzonello C., Mancardi M., Ruggieri M., Catassi C.: Gluten psychosis: Confirmation of a new clinical entity. Nutrients, 2015; 7: 5532-5539
  Google Scholar
• 80. Luostarinen L., Himanen S.L., Luostarinen M., Collin P., Pirttilä T.: Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J. Neurol. Neurosurg. Psychiatry, 2003; 74: 490-494
  Google Scholar
• 81. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., Londei M.: Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet, 2003; 362: 30-37
  Google Scholar
• 82. Mavroudi A., Karatza E., Papastavrou T., Panteliadis C., Spiroglou K.: Successful treatment of epilepsy and celiac disease with a gluten-free diet. Pediatr. Neurol., 2005; 33: 292-295
  Google Scholar
• 83. Mocan O., Dumitrascu D.L.: The broad spectrum of celiac disease and gluten sensitive enteropathy. Clujul. Med., 2016; 89: 335-342
  Google Scholar
• 84. Molina-Infante J., Santolaria S., Sanders D.S., Fernández-Bañares F.: Systematic review: noncoeliac gluten sensitivity. Aliment. Pharmacol. Ther., 2015; 41: 807-820
  Google Scholar
• 85. Muhle R., Trentacoste S.V., Rapin I.: The genetics of autism. Pediatrics, 2004; 113: e472-e486
  Google Scholar
• 86. Mulloy A., Lang R., O’Reilly M., Sigafoos J., Lancioni G., Rispoli M.: Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review. Res. Autism Spectr. Disord., 2010; 4: 328-339
  Google Scholar
• 87. Niederhofer H.: Association of attention-deficit/hyperactivity disorder and celiac disease: A brief report. Prim. Care Companion CNS Disord., 2011; 13: PCC.10br01104
  Google Scholar
• 88. O’Banion D., Armstrong B., Cummings R.A., Stange J.: Disruptive behavior: A dietary approach. J. Autism Child. Schizophr., 1978; 8: 325-337
  Google Scholar
• 89. Ortiz-Sánchez J.P., Cabrera-Chávez F., de la Barca A.M.: Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients. Nutrients, 2013; 5: 4174-4183
  Google Scholar
• 90. Panksepp J.: A neurochemical theory of autism. Trends Neurosci., 1979; 2: 174-177
  Google Scholar
• 91. Paul F., Pfueller C.F., Wuerfel J.T., Egerer K., Tanczos B., Baumgart D.C., Zipp F.: Celiac antibodies in the diagnostic workup of white matter lesions. Neurology, 2008; 71: 223-225
  Google Scholar
• 92. Peltola M., Kaukinen K., Dastidar P., Haimila K., Partanen J., Haapala A.M., Mäki M., Keränen T., Peltola J.: Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity. J. Neurol. Neurosurg. Psychiatry, 2009; 80: 626-630
  Google Scholar
• 93. Picarelli A., Libanori V., De Nitto D., Saponara A., Di Tola M., Donato G.: Organ culture system as a means to detect celiac disease. Ann. Clin. Lab. Sci., 2010; 40: 85-87
  Google Scholar
• 94. Pietzak M., Naon H.: Celiac disease and non-celiac gluten sensitivity. Ann. Pediatr. Child Health, 2015; 3: 1041
  Google Scholar
• 95. Pruimboom L., de Punder K.: The opioid effects of gluten exorphins: asymptomatic celiac disease. J. Health Popul. Nutr., 2015; 33: 24
  Google Scholar
• 96. Rajapakse T., Garcia-Rosales A., Weerawardene S., Cotton S., Fraser R.: Themes of delusions and hallucinations in first-episode psychosis. Early Interv. Psychiatry, 2011; 5: 254-258
  Google Scholar
• 97. Reichelt K.L., Jensen D.: IgA antibodies against gliadin and gluten in multiple sclerosis. Acta Neurol. Scand., 2004; 110: 239-241
  Google Scholar
• 98. Reichelt K.L., Sagedal E., Landmark J., Sangvik B.T., Eggen O., Scott H.: The effect of gluten-free diet on urinary peptide excretion and clinical state in schizophrenia. J. Ontomol. Med., 1990; 5: 223-239
  Google Scholar
• 99. Rewers M.: Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology, 2005; 128: S47-S51
  Google Scholar
• 100. Riedel O.: Burden and epidemiology of neuropsychiatric disorders. Public Health Forum, 2016; 24: 121-123
  Google Scholar
• 101. Rodrigo L., Hernández-Lahoz C., Fuentes D., Alvarez N., López-Vázquez A., González S.: Prevalence of celiac disease in multiple sclerosis. BMC Neurol., 2011; 11: 31
  Google Scholar
• 102. Rodrigo L., Hernández-Lahoz C., Lauret E., Rodriguez-Peláez M., Soucek M., Ciccocioppo R., Kruzliak P.: Gluten ataxia is better classified as non-celiac gluten sensitivity than as celiac disease: a comparative clinical study. Immunol. Res., 2016; 64: 558-564
  Google Scholar
• 103. Rostom A., Murray J.A., Kagnoff M.F.: American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology, 2006; 131: 1981-2002
  Google Scholar
• 104. Samaroo D., Dickerson F., Kasarda D.D., Green P.H., Briani C., Yolken R.H., Alaedini A.: Novel immune response to gluten in individuals with schizophrenia. Schizophr. Res., 2010; 118: 248-255
  Google Scholar
• 105. Sapone A., Bai J.C., Ciacci C., Dolinsek J., Green P.H., Hadjivassiliou M., Kaukinen K., Rostami K., Sanders D.S., Schumann M., Ullrich R., Villalta D., Volta U., Catassi C., Fasano A.: Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med., 2012; 10: 13
  Google Scholar
• 106. Sapone A., Lammers K.M., Mazzarella G., Mikhailenko I., Cartenì M., Casolaro V., Fasano A.: Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int. Arch. Allergy Immunol., 2010; 152: 75-80
  Google Scholar
• 107. Schnaar R.L.: Gangliosides of the vertebrate nervous system. J. Mol. Biol., 2016; 428: 3325-3336
  Google Scholar
• 108. Schumann M., Siegmund B., Schulzke J.D., Fromm M.: Celiac disease: Role of the epithelial barrier. Cell. Mol. Gastroenterol. Hepatol., 2017; 3: 150-162
  Google Scholar
• 109. Severance E.G., Yolken R.H., Eaton W.W.: Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr. Res., 2016; 176: 23-35
  Google Scholar
• 110. Singh M.M., Kay S.R.: Wheat gluten as a pathogenic factor in schizophrenia. Science, 1976; 191: 401-402
  Google Scholar
• 111. Smecuol E., Sugai E., Niveloni S., Vázquez H., Pedreira S., Mazure R., Moreno M.L., Label M., Mauriño E., Fasano A., Meddings J., Bai J.C.: Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin. Gastroenterol. Hepatol., 2005; 3: 335-341
  Google Scholar
• 112. Storms L.H., Clopton J.M., Wright C.: Effects of gluten on schizophrenics. Arch. Gen. Psychiatry, 1982; 39: 323-327
  Google Scholar
• 113. Subhan F.B., Chan C.B.: Review of dietary practices of the 21st century: facts and fallacies. Can. J. Diabetes, 2016; 40: 348-354
  Google Scholar
• 114. Tomaka J., Karakuła-Juchnowicz H., Morylowska-Topolska J., Dzikowski M., Juchnowicz D., Flis M., Siek A., Próchnicki M.: Gluten-related disorders and schizophrenia – potential linking mechanisms, diagnostic and therapeutic challenge. Curr. Probl. Psychiatry, 2017; 18: 9-24
  Google Scholar
• 115. Tripathi A., Lammers K.M., Goldblum S., Shea-Donohue T., Netzel-Arnett S., Buzza M.S., Antalis T.M., Vogel S.N., Zhao A., Yang S., Arrietta M.C., Meddings J.B., Fasano A.: Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc. Natl. Acad. Sci. USA, 2009; 106: 16799-16804
  Google Scholar
• 116. Tursi A., Giorgetti G.M., Iani C., Arciprete F., Brandimarte G., Capria A., Fontana L.: Peripheral neurological disturbances, autonomic dysfunction, and antineuronal antibodies in adult celiac disease before and after a gluten-free diet. Dig. Dis. Sci., 2006; 51: 1869-1874
  Google Scholar
• 117. Volta U., Tovoli F., Cicola R., Parisi C., Fabbri A., Piscaglia M., Fiorini E., Caio G.: Serological tests in gluten sensitivity (nonceliac gluten intolerance). J. Clin. Gastroenterol., 2012; 46: 680-685
  Google Scholar
• 118. Wei J., Hemmings G.P.: Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia. Med. Hypotheses, 2005; 64: 547-552
  Google Scholar
• 119. Yang Y., Wan C., Li H., Zhu H., La Y., Xi Z., Chen Y., Jiang L., Feng G., He L.: Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal. Chem., 2006; 78: 3571-3576
  Google Scholar
• 120. Zakharyan R., Khoyetsyan A., Arakelyan A., Boyajyan A., Gevorgyan A., Stahelova A., Mrazek F., Petrek M.: Association of C1QB gene polymorphism with schizophrenia in Armenian population. BMC Med. Genet., 2011; 12: 126
  Google Scholar
• 121. Zelnik N., Pacht A., Obeid R., Lerner A.: Range of neurologic disorders in patients with celiac disease. Pediatrics, 2004; 113: 1672-1676
  Google Scholar

Full text